Systematic review finds low revision rates and favorable short-to-mid-term outcomes in shoulder arthroplasty using augmented glenoid components, highlighting their therapeutic utility.
Key Points
To assess clinical and radiological outcomes along with revision and complication rates in patients undergoing anatomical total shoulder arthroplasty with augmented glenoid components.
Systematic review searched MEDLINE, EMBASE, CENTRAL, and CINAHL databases from inception to February 2022.
Identified 18 studies encompassing 814 anatomical total shoulder arthroplasties across 800 participants with a mean follow-up of 3.7 years.
Primary glenohumeral osteoarthritis represented nearly 70% of indications, with type B2 glenoid morphology present in 73% of cases.
Implants consisted mostly of all-polyethylene material (81%) utilizing full wedge (45%) or stepped (38%) designs, yielding good clinical outcomes across most series.
A total of 17 patients (4%) required revision surgery during the mean 3.7-year follow-up period.